1-3 of 3
Anatoli Malyguine
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 2423: Phase I/II study of antitumor vaccination using lung cancer cells expressing murine α(1,3)galactosyltransferase (αGT) in non-small cell lung cancer (NSCLC)

John C. Morris, Gabriela R. Rossi, John E. Janik, Nancy Harold, Stefania Pittaluga, Anatoli Malyguine, Susan Strobl, Lucinda Tennant, Nicholas Vahanian, Charles J. Link
Journal: Cancer Research
Cancer Res (2010) 70 (8_Supplement): 2423.
https://doi.org/10.1158/1538-7445.AM10-2423
Published: 15 April 2010
View article titled, Abstract 2423: Phase I/II study of antitumor vaccination using lung cancer cells expressing murine α(1,3)galactosyltransferase (αGT) in non-small cell lung cancer (NSCLC)
Journal Articles

Immunity to Murine Prostatic Tumors: Continuous Provision of T-Cell Help Prevents CD8 T-Cell Tolerance and Activates Tumor-Infiltrating Dendritic Cells

Kimberly A. Shafer-Weaver, Stephanie K. Watkins, Michael J. Anderson, Lauren J. Draper, Anatoli Malyguine, W. Gregory Alvord, Norman M. Greenberg, Arthur A. Hurwitz
Journal: Cancer Research
Cancer Res (2009) 69 (15): 6256–6264.
https://doi.org/10.1158/0008-5472.CAN-08-4516
Published: 29 July 2009
View article titled, Immunity to Murine Prostatic Tumors: Continuous Provision of T-Cell Help Prevents CD8 T-Cell Tolerance and Activates Tumor-Infiltrating Dendritic Cells
Open the PDF for Immunity to Murine Prostatic Tumors: Continuous Provision of T-Cell Help Prevents CD8 T-Cell Tolerance and Activates Tumor-Infiltrating Dendritic Cells in another window
Includes: Supplementary data
Journal Articles

A modified IFN-γ ELISPOT assay to detect specific responses to human primary tumor cells

Susan L. Strobl, Sattva Neelapu, Kimberly Shafer-Weaver, Tracy Ulderich, Michael Baseler, Larry Kwak, Anatoli Malyguine
Journal: Cancer Research
Cancer Res (2004) 64 (7_Supplement): 283.
Published: 01 April 2004
View article titled, A modified IFN-γ ELISPOT assay to detect specific responses to human primary tumor cells